Skip to main content
Presentation
View the updated corporate deck and neoadjuvant colon cancer strategy for BOT+BAL

Corporate Presentation

Review Events

Upcoming & Recent Events

September 10, 2026 4:30 PM

Agenus Stakeholder Webcast | September 2026

Webcast
2026
Add to calendar
August 6, 2026 7:30 AM

Agenus Q2 2026 Earnings

2026
July 13, 2026 8:30 AM

Agenus PIPE Financing Announcement

2026
Add this event to your calendar

Choose a calendar. You’ll be redirected or an .ics file will be downloaded with the event details pre-filled.

Title:
Agenus Stakeholder Webcast | September 2026
Date:
September 10, 2026
Time:
4:30 pm
Location:
Webcast
10.09.2026
G
Google Calendar
Opens Google Calendar in a new tab
O
Outlook Calendar
Opens Outlook Calendar
A
Apple Calendar (.ics)
Downloads an ICS file
Add this event to your calendar

Choose a calendar. You’ll be redirected or an .ics file will be downloaded with the event details pre-filled.

Title:
Agenus Q2 2026 Earnings
Date:
August 6, 2026
Time:
7:30 am
06.08.2026
G
Google Calendar
Opens Google Calendar in a new tab
O
Outlook Calendar
Opens Outlook Calendar
A
Apple Calendar (.ics)
Downloads an ICS file
Add this event to your calendar

Choose a calendar. You’ll be redirected or an .ics file will be downloaded with the event details pre-filled.

Title:
Agenus PIPE Financing Announcement
Date:
July 13, 2026
Time:
8:30 am
Location:
13.07.2026
G
Google Calendar
Opens Google Calendar in a new tab
O
Outlook Calendar
Opens Outlook Calendar
A
Apple Calendar (.ics)
Downloads an ICS file

Archived Events

Select Year
All Years
Link Template
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
January 29, 2019 12:00 AM

Biotech Electronic Security Token (BEST) FAQs

2019
December 20, 2018 9:30 AM

Gilead and Agenus Enter Into Collaboration To Develop Immuno-Oncology Therapies

2018
November 16, 2018 12:00 AM

Agenus Statement

2018
November 14, 2018 8:40 AM

2018 Jefferies London Healthcare Conference

2018
November 6, 2018 9:30 AM

Agenus Third Quarter 2018 Financial Results

2018

Investor Email Alerts

Sign Up
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Contact Us

Agenus Inc.
investor@agenusbio.com

Quick Links

SEC Filings
Information Request Form
Request A Meeting With Management
Agenus Inc.
3 Forbes Road
Lexington, MA 02421-7305
T: +1 (781) 674 4400 | F: +1 (781) 674 4200
Our Science
Pipeline
Publications
Clinical Trials
Immunotherapy
About BOT + BAL
Company
Our History
Our Team
Careers
Partners
Access
Patient Access
Contact Medical Affairs
Resources
Press Releases
In the News
Patient Resources
FAQs
Investors
Investor Overview
Events
Financial Information
Opt-out preferencesCookie PolicyTerms and Conditions of UsePrivacy PolicyCommunity GuidelinesAccess to Investigational Medicines PolicyReport Adverse EventInvestor Portal
© 2025 Agenus Inc. All rights reserved.